Ask Aeroz

Type the question you actually came here with.

Pakistan · DRAP

Pakistan drug serialization: DRAP track and trace from 9 October 2026.

In Pakistan, DRAP's Pharmaceutical Track and Trace System has required a 2D Data Matrix barcode and serial number on all locally manufactured and imported pharmaceutical products since 9 October 2026, under S.R.O. 963(I)/2026 amending the Drugs (Labelling and Packing) Rules, 1986.

Pakistan's drug serialization rule is in force. S.R.O. 963(I)/2026 of 9 June 2026 amended the Drugs (Labelling and Packing) Rules, 1986, and since 9 October 2026 DRAP requires a unique 2D Data Matrix barcode and serial number on all locally manufactured and imported pharmaceutical products. Batches with an earlier manufacturing date are exempt.

DRAPS.R.O. 963(I)/20262D Data MatrixSerialisationIn force
Key facts · reviewed

Pakistan, in three facts.

Pakistan · Drug Regulatory Authority of Pakistan (DRAP) · S.R.O. 963(I)/2026 of 9 June 2026 amends the Drugs (Labelling and Packing) Rules, 1986 · 2D Data Matrix and serial number from 9 October 2026.

What the rule requires

A serial on every pack, made here or imported.

The rule

S.R.O. 963(I)/2026 of 9 June 2026 amended the Drugs (Labelling and Packing) Rules, 1986. It made DRAP's Pharmaceutical Track and Trace System, with a 2-D barcode and serialisation, mandatory from 9 October 2026, four months after the notification, for pharmaceutical products for human and veterinary use.

Phase 1: local and imported products

DRAP's circular of 8 October 2026 says phase 1 covers all locally manufactured and imported pharmaceutical products. Each needs a unique 2D Data Matrix barcode and serial number, following DRAP's guidelines on GS1 Data Matrix barcodes and serialisation.

Older batches are exempt

Batches manufactured locally or imported with a manufacturing date before 9 October 2026 are exempt and remain permitted for import, distribution and sale. DRAP says it will take legal action for non-compliance.

Data through eApp

Before launch, DRAP required licensing and product data to be verified and validated on its eApp software for integration with the track and trace system, with the deadline extended to 5 September 2026.

The dates

The timeline, as it stands.

DRAP describes the system as rolled out in phases. Phase 1 covers locally manufactured and imported pharmaceutical products; check DRAP's notifications before planning for later phases.

S.R.O. 963(I)/2026 notified9 Jun 2026
eApp data validation deadline5 Sep 2026
2D barcode and serial number mandatorysince 9 Oct 2026
What to do now

Three moves that de-risk the deadline.

01 · Step

Check every product you ship to Pakistan

Imports are covered: any batch made or imported with a manufacturing date on or after 9 October 2026 needs the 2D Data Matrix and serial number.

02 · Step

Keep your eApp data clean

The track and trace system draws on the licensing and product data held in DRAP's eApp. Errors there show up as failed checks downstream.

03 · Step

Serve other markets from the same data

Plants that supply Pakistan, the EU and the US print a 2D code for each. One serialisation design can serve all three.

How Aeroz fits

A serial, and proof behind it.

A serial number tells a pharmacist which pack it should be, and a copied code tells them the same thing. Aeroz adds an identity to the pack or case that answers each tap with a signed response, so a distributor or pharmacist can tell the genuine product from a pack carrying a copied code.

FAQ

Pakistan, answered.

What is DRAP's drug serialization requirement?

Under S.R.O. 963(I)/2026, which amended the Drugs (Labelling and Packing) Rules, 1986, every locally manufactured or imported pharmaceutical product needs a unique 2D Data Matrix barcode and serial number from 9 October 2026, reported through DRAP's Pharmaceutical Track and Trace System.

From when is the 2D barcode mandatory in Pakistan?

From 9 October 2026, four months after the notification of 9 June 2026.

Does it apply to imported medicines?

Yes. DRAP's circular of 8 October 2026 says phase 1 covers locally manufactured and imported pharmaceutical products alike.

What happens to stock made before 9 October 2026?

Batches manufactured or imported with a manufacturing date before 9 October 2026 are exempt and remain permitted for import, distribution and sale.

Readiness audit

Know exactly where you stand, in 14 days.

A fixed-fee Aeroz audit maps your products against Pakistan's DRAP track and trace, 2D barcode and serialisation requirements and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.

Fixed fee: Readiness Report $2,500, Readiness Audit $4,500 14-day written report No commitment to proceed